INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr | ₹218 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹286 Cr |
| Mar2022 | ₹326 Cr |
| Mar2021 | ₹218 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | -58.02 | |
| Mar2024 | ₹236 Cr | -17.35 | |
| Mar2023 | ₹286 Cr | -12.32 | |
| Mar2022 | ₹326 Cr | 49.43 | |
| Mar2021 | ₹218 Cr | - | |
Compare Operating Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,404.6 Cr | -1.7% | -11.1% | -13.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.7% |
-11.1% |
-13.2% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses